Medical cures have been derived from embryonic stem cells
While embryonic stem cells hold immense theoretical promise for regenerative medicine and disease cures, actual clinical applications have predominantly relied on adult stem cells (such as mesenchymal stem cells) or induced pluripotent stem cells, leaving direct cures derived specifically from embryonic stem cells less established in routine clinical practice.
The claim states that medical cures have been derived specifically from embryonic stem cells. The retrieved literature demonstrates that while embryonic stem cells (ESCs) show great potential in preclinical and in vitro research (e.g., Papers 0, 4, 6), actual clinical trials and established treatments heavily favor adult stem cells like mesenchymal stem cells (MSCs) or induced pluripotent stem cells (iPSCs) due to safety concerns, ethical hurdles, and tumorigenic risks associated with ESCs (e.g., Papers 5, 7, 10). Therefore, the claim is contested regarding whether actual medical cures have been successfully derived from embryonic stem cells specifically, as opposed to other stem cell types.
Wojciech Zakrzewski, Maciej Dobrzyński, Maria Szymonowicz, Zbigniew Rybak. Stem cells: past, present, and future. 2019. https://doi.org/10.1186/s13287-019-1165-5
Paper [0] reviews the discovery and derivation of various stem cells, highlighting their potential to treat presently untreatable diseases.
Carla Herberts, Marcel Kwa, Harm PH Hermsen. Risk factors in the development of stem cell therapy. 2011. https://doi.org/10.1186/1479-5876-9-29
Paper [7] notes that currently there is no extensive clinical experience with pluripotent stem cells like embryonic stem cells due to high tumor formation risks and ethical constraints.
See more details
Duc M. Hoang, Phuong T. Pham, Trung Q. Bach, Anh Toan Ngo, Quyen T. Nguyen, Trang T. K. Phan, Nguyễn Hoàng Giang, Phuong Thi-Bich Le, Van T. Hoang, Nicholas R. Forsyth, Michael Heke, Nguyễn Thanh Liêm. Stem cell-based therapy for human diseases. 2022. https://doi.org/10.1038/s41392-022-01134-4
Paper [4] outlines how human pluripotent and mesenchymal stem cells have emerged as key players in regenerative medicine for treating various human diseases.
Ramyar Rahimi Darehbagh, Seyedeh Asrin Seyedoshohadaei, Rojin Ramezani, Nima Rezaei. Stem cell therapies for neurological disorders: current progress, challenges, and future perspectives.. 2024. https://doi.org/10.1186/s40001-024-01987-1
Paper [10] indicates that while embryonic stem cells are studied preclinically, clinical trials have primarily relied on adult stem cells rather than embryonic stem cells.
The paper trail · every fact has a biography
Challenge the receipt
Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.
Terms · Privacy · How verdicts work · Dispute this receipt